You should not use Strattera if you have narrow-angle glaucoma, a tumor in the adrenal glands, heart disease or coronary heart disease, or moderate to severe high blood pressure. Do not utilize Strattera if you have taken an MAO inhibitor in the earlier period of 14 days, together with isocarboxazid, linezolid, methylene blue vaccination, phenelzine, rasagiline, selegiline, tranylcypromine, and others.
Strattera can cause new or worsening psychosis (unusual thoughts or behaviors), especially if you have a history of depression, mental illness or bipolar disorder. Strattera has caused heart attack and unexpected demise in community with high blood pressure, heart ailment or a heart fault. Some young people have thoughts of suicide when they start taking this medication for the first time or when the dose is changed. Be attentive to changes in your mood or symptoms, particularly if you have constantly had suicidal feelings.
Before taking this medicine
You should not use this medication if you are allergic to atomoxetine, or if you have:
- serious problems of the heart or blood vessels;
- Narrow-angle glaucoma; or
- Pheochromocytoma (tumor of the adrenal gland).
- Strattera has caused apoplexy, heart attack and sudden death in certain people.
Tell your doctor if you have:
- heart problems or a congenital heart defect;
- high blood pressure; or
- Family account of heart ailment or unexpected demise.
To make sure this medication is safe for you, tell your doctor if you have ever had:
- depression, mental illness, bipolar disorder, psychosis;
- suicidal thoughts or actions;
- low blood pressure; or
- Liver disease.
Some young people have thoughts of suicide when they take Strattera for the first time, or when the dose is changed. Your physician must check your development at usual visits. Your folks or other caregivers must as well be attentive to changes in your feelings or symptoms.
It is not known if this medicine will harm the unborn baby. Tell your physician if you are expecting or planning to become pregnant. It is not recognized whether atomoxetine releases into breast milk or if it might affect an infant. Tell your physician if you are breast-feeding an infant. Strattera is not approved for use by persons less than 6 years of age.